Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06013410

Pathophysiological Effects of Persistently Colonized Microbiome on Irritable Bowel Syndrome

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
30 (estimated)
Sponsor
Second Affiliated Hospital, School of Medicine, Zhejiang University · Academic / Other
Sex
All
Age
18 Years – 50 Years
Healthy volunteers
Accepted

Summary

The goal of this clinical trial is to explore the pathophysiological effects of the persistently colonized microbiome in irritable bowel syndrome (IBS) patients. The main questions it aims to answer are: Question 1: the microbiome difference of the biofilm between IBS and healthy patients. Question 2: the metabolic product patterns between IBS and healthy patients. Participants will need to take a colonoscopy examination, two gut mucosal biopsy samples will be collected during the examination. Researchers will compare the IBS and healthy control groups to see if there was the disease-specific pattern in the microbiome and metabolic product of the biofilm.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTcolonoscopycolonoscopy

Timeline

Start date
2023-08-25
Primary completion
2026-05-10
Completion
2026-05-15
First posted
2023-08-28
Last updated
2023-08-28

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06013410. Inclusion in this directory is not an endorsement.

Pathophysiological Effects of Persistently Colonized Microbiome on Irritable Bowel Syndrome (NCT06013410) · Clinical Trials Directory